Transcriptomic profiling of co-cultured cancer-host cells identifies hypoxia as a driver of the skeletal muscle cell’s antiproliferative effect on cancer cells
RNA-seq (gene expression) · mouse · 28 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 28 samples: 7 conditions, mostly in duplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Transcriptomic profiling of co-cultured cancer-host cells identifies hypoxia as a driver of the skeletal muscle cell's anti-proliferative effect on cancer cellsOncogenesis · 2026
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE299422_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1274402 and SRA study SRP591031. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 14 samples.
How we read this: 7 replicated groups read from 28 sample titles; they account for 14 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9039000 R2C2C12P1
- GSM9039001 R3C2C12P1 R3C2C12P
- GSM9039002 R3C2C12P2 R3C2C12P
- GSM9039003 R5C2C12P1
- GSM9039004 R3MLgP2
- GSM9039005 R5MLgP2
- GSM9039006 R6MLgP1 R6MLgP
- GSM9039007 R6MLgP2 R6MLgP
- GSM9039008 R3EO771P1 R3EO771P
- GSM9039009 R3EO771P2 R3EO771P
- GSM9039010 R5EO771P1
- GSM9039011 R6EO771P2
- GSM9039012 R3C2C12E1
- GSM9039013 R5C2C12E1 R5C2C12E
- GSM9039014 R5C2C12E2 R5C2C12E
- GSM9039015 R6C2C12E1
- GSM9039016 R5EO771C1 R5EO771C
- GSM9039017 R5EO771C2 R5EO771C
- GSM9039018 R6EO771C1
- GSM9039019 R3EO771C1
- GSM9039020 R5MLgE1
- GSM9039021 R6MLgE1 R6MLgE
- GSM9039022 R6MLgE2 R6MLgE
- GSM9039023 R7MLgE1
- GSM9039024 R6EO771M1 R6EO771M
- GSM9039025 R5EO771M1
- GSM9039026 R6EO771M2 R6EO771M
- GSM9039027 R7EO771M1
- GSE271053 A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer [RNA-Seq] 43 samples shares identifies, driver
- GSE271066 A forward genetic screen identifies Sirtuin1 as a driver of neuroendocrine prostate cancer. 44 samples shares identifies, driver
- GSE246779 Single-cell multimodal profiling of atherosclerosis identifies CD200 as a cell surface lineage marker of vascular smooth muscle cells and their derived cells 24 samples shares identifies, muscle
- GSE275471 Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4+ T cell response 857 samples shares identifies
- GSE309251 Western diet-induced MASH in PWK/PhJ mice identifies disruptions in amino acid and sphingolipid metabolism contributing to cardiac dysfunction 347 samples shares identifies
- GSE215960 Subclonal evolution revealed by single-cell profiles of expressed mutations identifies adaptation mechanisms to immunotherapy in melanoma [scRNA-seq] 192 samples shares identifies
- GSE299686 Longitudinal liquid biopsy identifies an early predictive biomarker of immune checkpoint blockade response in head and neck squamous cell carcinoma [bulk RNA-seq] 178 samples shares identifies
- GSE293874 Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity [mouse bulk RNA-seq] 167 samples shares identifies
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.